3 employees
Ysotope's objective is to design, validate, and monetize new targeted radiopharmaceuticals for precision oncology.
2022
YSOTOPE THERANOSTICS raised undisclosed on March 29, 2023
Investors: EDEM Escuela de Empresarios and Angels Capital
YSOTOPE THERANOSTICS raised undisclosed on March 20, 2023
Investors: Ship2B